Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Goessl

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Urology|May 19, 2001
Reverse transcriptase-polymerase chain reaction for prostate-specific antigen in the molecular staging of pelvic surgical margins after radical prostatectomyB Straub, M Müller, H Krause, et al.
Cancer Research|November 21, 2000
Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluidsC Goessl, H Krause, M Müller, et al.
Prostaglandins|March 1, 1994
Differential induction of eicosanoid synthesis in monocytic cells treated with retinoic acid and 1,25-dihydroxy-vitamin D3A Sellmayer, C Goessl, H Obermeier, et al.
Cancer Research|October 27, 1998
Microsatellite analysis of plasma DNA from patients with clear cell renal carcinomaC Goessl, R Heicappell, R Münker, et al.
International Journal of Molecular Medicine|April 7, 2004
Detection of germ-cell-tumor-specific gene products in peripheral blood by immunomagnetic tumor cell enrichment followed by RT-PCRM Schrader, L Weissbach, M Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancerC Goessl, J Plaschke, S Pistorius, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2012
Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancerR B Egerdie, F Saad, M R Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerM E Robson, N Tung, P Conte, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Urology|May 19, 2001
Reverse transcriptase-polymerase chain reaction for prostate-specific antigen in the molecular staging of pelvic surgical margins after radical prostatectomyB Straub, M Müller, H Krause, et al.
Cancer Research|November 21, 2000
Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluidsC Goessl, H Krause, M Müller, et al.
Prostaglandins|March 1, 1994
Differential induction of eicosanoid synthesis in monocytic cells treated with retinoic acid and 1,25-dihydroxy-vitamin D3A Sellmayer, C Goessl, H Obermeier, et al.
Cancer Research|October 27, 1998
Microsatellite analysis of plasma DNA from patients with clear cell renal carcinomaC Goessl, R Heicappell, R Münker, et al.
International Journal of Molecular Medicine|April 7, 2004
Detection of germ-cell-tumor-specific gene products in peripheral blood by immunomagnetic tumor cell enrichment followed by RT-PCRM Schrader, L Weissbach, M Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancerC Goessl, J Plaschke, S Pistorius, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2012
Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancerR B Egerdie, F Saad, M R Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerM E Robson, N Tung, P Conte, et al.
Pageof 3